Pharmacists in Greenlawn, NY Accepting Medicare

12 Pharmacists found. Showing 1 - 12

Mr. Paul Korman, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 106 Broadway, Greenlawn, NY 11740 Phone: 631-757-8200    Fax: 631-757-7656

Mr. Thomas M Rosselli Sr., RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 106 Broadway, Greenlawn, NY 11740 Phone: 631-757-8200

Frank Campise, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 51 Broadway, Greenlawn, NY 11740 Phone: 631-261-2233

Richard C Ward, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 51 Broadway, Greenlawn, NY 11740 Phone: 631-261-2233    Fax: 631-261-0705

Mr. David Nussbaum Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 777 Pulaski Rd, Greenlawn, NY 11740 Phone: 516-921-5494

Teresa G Gambardella, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 20 Wells Rd, Greenlawn, NY 11740 Phone: 631-368-4098    Fax: 631-261-6371

John A Calamis Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 106 Broadway, Greenlawn, NY 11740 Phone: 631-754-0532    Fax: 631-651-8414

Mr. Steven Irwin Gerson, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 51 Broadway, Greenlawn, NY 11740 Phone: 631-261-2233    Fax: 631-261-0705

Richard Miola, R. PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 106 Broadway, Greenlawn, NY 11740 Phone: 631-757-8200    Fax: 631-757-7656

Harvey J Fox, R PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 106 Broadway, Greenlawn, NY 11740 Phone: 631-754-0532

Michelle L Pedersen, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 51 Broadway, Greenlawn, NY 11740 Phone: 631-261-2233    Fax: 631-261-0705

Michael H Lowenthal Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 110 Broadway, Greenlawn, NY 11740 Phone: 631-757-8200

News Archive

Forest Laboratories, Almirall report positive topline results from AUGMENT COPD

Forest Laboratories, Inc. and Almirall, S.A. today announced positive topline results from AUGMENT COPD, the second six-month pivotal phase III clinical trial evaluating the efficacy and safety of investigational fixed dose combinations of aclidinium bromide and formoterol fumarate, delivered in the Pressair (Genuair outside the USA) inhaler.

Health reform policy: Flexible spending, device taxes and waivers

One health law provision will be a bummer for people who use the tax-free dollars stored in flexible spending accounts, Kaiser Health News reports. "Starting in January, you'll no longer be able to use your FSA for over-the-counter drugs and medicines unless you have a doctor's prescription. Experts agree that the new rules will likely discourage people from tapping their FSAs for routine purchases of aspirin, vitamins, cough medicine and other drugstore essentials" (Andrews, 11/8).

National Marfan Foundation's annual conference to be held in Chicago

The National Marfan Foundation is gearing up for its 28th Annual conference, held at Northwestern Memorial Hospital in Chicago, August 2-5. Hosted by Northwestern Medicine- and the Ann and Robert H. Lurie Children's Hospital of Chicago, the four-day conference has something for everyone with Marfan syndrome (MFS) and related disorders, including access to many of the top MFS experts in the world.

Potential toxicity of zinc nanoparticles in sunscreen products

Scientists are reporting that particle size affects the toxicity of zinc oxide, a material widely used in sunscreens. Particles smaller than 100 nanometers are slightly more toxic to colon cells than conventional zinc oxide. Solid zinc oxide was more toxic than equivalent amounts of soluble zinc, and direct particle to cell contact was required to cause cell death. Their study is in ACS' Chemical Research in Toxicology, a monthly journal.

Read more Medical News

› Verified 7 days ago